Corteva, Inc. $CTVA Shares Bought by Osaic Holdings Inc.

Osaic Holdings Inc. grew its position in Corteva, Inc. (NYSE:CTVA) by 22.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 179,933 shares of the company’s stock after acquiring an additional 32,419 shares during the period. Osaic Holdings Inc.’s holdings in Corteva were worth $13,361,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Gladwyn Financial Advisors Inc. acquired a new position in Corteva during the 2nd quarter worth approximately $25,000. Total Investment Management Inc. purchased a new stake in shares of Corteva in the second quarter valued at approximately $27,000. Curat Global LLC grew its holdings in Corteva by 93.7% during the second quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after acquiring an additional 179 shares during the period. Maryland Capital Advisors Inc. purchased a new position in Corteva in the second quarter worth $29,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in Corteva in the second quarter valued at $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Down 0.9%

CTVA stock opened at $66.39 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.07. The company’s 50 day simple moving average is $64.54 and its 200-day simple moving average is $69.33. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $77.41. The firm has a market capitalization of $44.86 billion, a PE ratio of 28.37, a P/E/G ratio of 1.52 and a beta of 0.74.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.26. The firm had revenue of $2.62 billion for the quarter, compared to analyst estimates of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.Corteva’s revenue was up 6.5% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.49) EPS. Equities analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Monday, December 1st were given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date was Monday, December 1st. Corteva’s dividend payout ratio (DPR) is currently 30.77%.

Analysts Set New Price Targets

CTVA has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. Mizuho lowered their target price on shares of Corteva from $85.00 to $78.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 8th. Royal Bank Of Canada reduced their price target on shares of Corteva from $86.00 to $80.00 and set an “outperform” rating for the company in a research report on Friday, October 17th. Argus lowered their price target on Corteva from $83.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, October 13th. Finally, BMO Capital Markets set a $86.00 price objective on Corteva in a research note on Monday, September 15th. Sixteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $78.21.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.